DNA binding and topoisomerase II inhibitory activity of water-soluble ruthenium(II) and rhodium(III) complexes

被引:77
作者
Singh, Sanjay Kumar
Joshi, Shweta
Singh, Alok Ranjan
Saxena, Jitendra Kumar
Pandey, Daya Shankar [1 ]
机构
[1] Banaras Hindu Univ, Fac Sci, Dept Chem, Varanasi 221005, Uttar Pradesh, India
[2] Cent Drug Res Inst, Div Biochem, Lucknow 226001, Uttar Pradesh, India
关键词
D O I
10.1021/ic700885m
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Water-soluble piano-stool arene ruthenium complexes based on 1-(4-cyanophenyl)imidazole (CPI) and 4-cyanopyridine (CNPy) with the formulas [(eta(6)-arene)RuCl2(L)] (L = CPl, eta(6)-arene = benzene (1), p-cymene (2), hexamethyl benzene (3); L = CNPy, eta(6)-arene = benzene (4), p-cymene (5), h examethylbenzene (6)) have been prepared by our earlier methods. The molecular structure of [(eta(6) -C6Me6)RuCl2(CNPy)] (6) has been determined crystallographically. Analogous rhodium(III) complex [(eta(5)-C5Me5)RhCl2(CPI)] (7) has also been prepared and characterized. DNA interaction with the arene ruthenium complexes and the rhodiurn complex has been examined by spectroscopic and gel mobility shift assay; condensation of DNA and B -> Z transition have also been described. Arene ruthenium(II) and EPh3 (E = P, As)-containing arene ruthenium(II) complexes exhibited strong binding behavior, however, rhodium(111) complexes were found to be Topo 11 inhibitors with an inhibition percentage of 70% (7) and 30% (7a). Furthermore, arene ruthenium complexes containing polypyridyl ligands also act as mild Topo 11 inhibitors (10%, 3c and 40%, 3d) in contrast to their precursor complexes. Complexes 4-6 also show significant inhibition of beta-hematin/hemozoin formation activity.
引用
收藏
页码:10869 / 10876
页数:8
相关论文
共 79 条
[1]   In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer [J].
Aird, RE ;
Cummings, J ;
Ritchie, AA ;
Muir, M ;
Morris, RE ;
Chen, H ;
Sadler, PJ ;
Jodrell, DI .
BRITISH JOURNAL OF CANCER, 2002, 86 (10) :1652-1657
[2]   [Ru(η6-p-cymene)Cl2(pta)] (pta=1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane):: a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells [J].
Allardyce, CS ;
Dyson, PJ ;
Ellis, DJ ;
Heath, SL .
CHEMICAL COMMUNICATIONS, 2001, (15) :1396-1397
[3]   Ruthenium(II) complexes of redox-related, modified dipyridophenazine ligands: Synthesis, characterization, and DNA interaction [J].
Ambroise, A ;
Maiya, BG .
INORGANIC CHEMISTRY, 2000, 39 (19) :4256-4263
[4]   Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis [J].
Ang, Wee Han ;
Daldini, Elisa ;
Scolaro, Claudine ;
Scopelliti, Rosario ;
Juillerat-Jeannerat, Lucienne ;
Dyson, Paul J. .
INORGANIC CHEMISTRY, 2006, 45 (22) :9006-9013
[5]   Classical and non-classical ruthenium-based anticancer drugs: Towards targeted chemotherapy [J].
Ang, Wee Han ;
Dyson, Paul J. .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2006, (20) :4003-4018
[6]   Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: Influence of the ligands on drug efficacies and uptake [J].
Ang, WH ;
Pilet, S ;
Scopelliti, R ;
Bussy, F ;
Juillerat-Jeanneret, L ;
Dyson, PJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (25) :8060-8069
[7]  
[Anonymous], 1999, TOP BIOL INORG CHEM
[8]   THE INTERACTION OF SPERMINE AND PENTAMINES WITH DNA [J].
BASU, HS ;
MARTON, LJ .
BIOCHEMICAL JOURNAL, 1987, 244 (01) :243-246
[9]   Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells [J].
Bergamo, A ;
Zorzet, S ;
Gava, B ;
Sorc, A ;
Alessio, E ;
Iengo, E ;
Sava, G .
ANTI-CANCER DRUGS, 2000, 11 (08) :665-672
[10]   Optically active transition metal complexes .107. Synthesis, properties, stereochemistry and crystal structures of diastereomeric benzene-ruthenium(II) complexes with a chiral salicylideneaminato ligand [J].
Brunner, H ;
Oeschey, R ;
Nuber, B .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1996, (08) :1499-1508